Geode Capital Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8M | Buy |
902,312
+121,403
| +16% | +$2.8M | ﹤0.01% | 1934 |
|
|
2025
Q1 | $21.1M | Buy |
780,909
+65,953
| +9% | +$1.78M | ﹤0.01% | 1871 |
|
|
2024
Q4 | $38.3M | Buy |
714,956
+52,362
| +8% | +$2.8M | ﹤0.01% | 1599 |
|
|
2024
Q3 | $30.1M | Buy |
662,594
+38,490
| +6% | +$1.75M | ﹤0.01% | 1747 |
|
|
2024
Q2 | $26.1M | Buy |
624,104
+156,557
| +33% | +$6.56M | ﹤0.01% | 1782 |
|
|
2024
Q1 | $17.6M | Buy |
467,547
+59,357
| +15% | +$2.24M | ﹤0.01% | 2000 |
|
|
2023
Q4 | $4.38M | Buy |
408,190
+21,386
| +6% | +$229K | ﹤0.01% | 2772 |
|
|
2023
Q3 | $3.9M | Buy |
386,804
+9,579
| +3% | +$96.6K | ﹤0.01% | 2767 |
|
|
2023
Q2 | $4.48M | Buy |
377,225
+22,640
| +6% | +$269K | ﹤0.01% | 2744 |
|
|
2023
Q1 | $4.29M | Buy |
354,585
+14,788
| +4% | +$179K | ﹤0.01% | 2702 |
|
|
2022
Q4 | $4.48M | Buy |
339,797
+5,276
| +2% | +$69.5K | ﹤0.01% | 2722 |
|
|
2022
Q3 | $4.53M | Buy |
334,521
+50,901
| +18% | +$689K | ﹤0.01% | 2733 |
|
|
2022
Q2 | $3.46M | Buy |
283,620
+8,389
| +3% | +$102K | ﹤0.01% | 2896 |
|
|
2022
Q1 | $3.95M | Buy |
275,231
+54,704
| +25% | +$784K | ﹤0.01% | 2934 |
|
|
2021
Q4 | $4.35M | Buy |
220,527
+8,647
| +4% | +$171K | ﹤0.01% | 2971 |
|
|
2021
Q3 | $4.58M | Buy |
211,880
+189,863
| +862% | +$4.11M | ﹤0.01% | 2956 |
|
|
2021
Q2 | $549K | Buy |
+22,017
| New | +$549K | ﹤0.01% | 3899 |
|